LUN and LUN.CO Related Headlines

Go Back

Jun 4, 2026 05:04PM Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

Mar 16, 2026 04:28AM Lundbeck presents Phase 1b data for Parkinson's drug at conference

Mar 16, 2026 04:27AM Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026

LUN and LUN.CO Related Press Releases

Go Back

Jun 4, 2026 05:04PM Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

Mar 16, 2026 04:27AM Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026

LUN and LUN.CO Related SEC Filings

Go Back